In cardiovascular diseases, proanthocyanidins exert their protective effect by inhibiting the oxidation of LDL-cholesteroland binding this molecule to the lectin-like oxidized LDL-1 receptor (LOX-1) involved in the pathogenesis of arteriosclerosis. This evidence concerns the gene OLR1 and arteriosclerosis disorder.